Data / Form D filings / Sinopsys Surgical, Inc.
Sinopsys Surgical, Inc.: Form D filings
Sinopsys Surgical, Inc., a biotechnology company in Boulder, CO, filed 4 Form D notices with the SEC between 2011 and 2014. The latest, on October 17, 2014, reports $8.3 million sold of a $8.3 million offering to 19 investors.
Find out what Sinopsys Surgical, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1110 Linden Ave, Boulder, CO, 80304
- Phone
- (303) 929-9909
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1511987
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2014 | New notice | $8,258,015 | $8,258,015 | $0 | 19 | Oct 3, 2014 | sec.gov |
| Oct 29, 2013 | New notice | $600,000 | $600,000 | $0 | 5 | Oct 25, 2013 | sec.gov |
| Jul 16, 2012 | New notice | $2,400,002 | $1,200,001 | $1,200,001 | 5 | Jul 12, 2012 | sec.gov |
| Apr 6, 2011 | New notice | $849,999 | $109,998 | $740,001 | 2 | Mar 9, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry Ross | Executive Officer, Director | |
| Donald Schomer | Director | |
| Robert Di Scipio | Director | |
| Mark Lupa | Director | |
| Jesse Aweida | Director | |
| Dan Watkins | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Oct 13, 2014 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sinopsys Surgical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.